Medico Remedies Ltd. (MEDICO) Share Price Falls 8.29% Amid Market Volatility
- August 5, 2026
- Posted by: Harsh Piplani
- Category: News
Medico Remedies Ltd. Share Price fell 8.29% to Rs 44.81, marking a significant decline in the micro cap category.
Medico Remedies Ltd. Share Price experienced a notable decline today, falling 8.29% to Rs 44.81. With a market capitalisation of Rs 405.46 crore, Medico Remedies Ltd. has caught the attention of investors and analysts alike. The decline in share price today highlights the volatility within the market, although the data does not specify a company-specific catalyst for this movement.
< The stock opened at Rs 44.81, which was also its high and low for the day, suggesting limited trading activity. The total volume recorded was 80 shares, with 50 shares traded on the BSE and 30 on the NSE. The turnover for the day was negligible, reflecting the low volume of trades. This price fall places Medico Remedies Ltd. among the top decliners in its category, drawing attention to its current market position.
Medico Remedies Ltd. (MEDICO) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 44.81 |
| Previous Close | Rs 48.86 |
| Today's Change | Rs -4.05 (-8.29%) |
| Day Open | Rs 44.81 |
| Day High | Rs 44.81 |
| Day Low | Rs 44.81 |
| Current Volume (BSE) | 50 |
| BSE Traded Volume | 50 |
| NSE Traded Volume | 30 |
| Combined NSE + BSE Volume | 80 |
| Turnover | Rs 0 crore |
| Market Capitalisation | Rs 405.46 crore |
| Market Cap Category | Micro Cap |
Medico Remedies Ltd. (MEDICO) traded at Rs 44.81. versus the previous close of Rs 48.86, a fall of 8.29%. The stock opened at Rs 44.81, reached Rs 44.81, touched Rs 44.81. Reported volume was 50.
Medico Remedies Ltd. (MEDICO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 405.46 crore |
| P/E Ratio | 30.91x |
| P/B Ratio | 5.37x |
| ROE | 8.31% |
| ROCE | 10.13% |
| EPS | Rs 1.58 |
| Dividend Yield | 0% |
Medico Remedies Ltd. was valued at a P/E ratio of 30.91x, a P/B ratio of 5.37x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 8.31% and ROCE of 10.13%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 1.58, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Medico Remedies Ltd. operates within the Pharmaceuticals & Drugs industry, with a market capitalisation of Rs 405.46 crore. The company’s P/E ratio is 30.91, which is above the industry median of 25.82 but below the average of 80.86, indicating a relatively high valuation compared to its peers. The P/B ratio stands at 5.37, significantly higher than the industry median of 1.85, suggesting that the stock may be overvalued on a book value basis.
The company’s return on equity (ROE) is 8.31%, slightly below the industry median of 10.59%, while the return on capital employed (ROCE) is 10.13%, also below the industry median of 12.98%. These figures indicate that Medico Remedies Ltd. is generating returns that are below the industry average, which may concern investors looking for higher profitability.
The earnings per share (EPS) is Rs 1.58, and the company does not currently offer a dividend yield, which may impact its attractiveness to income-focused investors. Overall, the fundamental analysis suggests that while Medico Remedies Ltd. is trading at a relatively high valuation, its profitability metrics are below industry standards, which could be a point of concern for potential investors.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 30.91x |
| Benchmark Median P/E | 25.82x |
| Benchmark Average P/E | 80.86x |
| Benchmark P/E Range | 3.39x to 3,385.56x |
| Company P/B Ratio | 5.37x |
| Benchmark Median P/B | 1.85x |
| Company ROE | 8.31% |
| Benchmark Median ROE | 10.59% |
| Company ROCE | 10.13% |
| Benchmark Median ROCE | 12.98% |
| Company Market Capitalisation | Rs 405.46 crore |
| Benchmark Median Market Cap | Rs 146.67 crore |
Medico Remedies Ltd. (MEDICO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Medico Remedies Ltd. (MEDICO) has a P/E ratio of 30.91x, which is above the benchmark median of 25.82x, a difference of +19.71%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Medico Remedies Ltd. (MEDICO) has a ROE of 8.31%, which is below the benchmark median of 10.59%, a difference of -21.53%. Medico Remedies Ltd. (MEDICO) has a ROCE of 10.13%, which is below the benchmark median of 12.98%, a difference of -21.96%.
Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Medico Remedies Ltd. is part of the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. The sector snapshot reveals that the company’s P/E ratio of 30.91 is above the industry median of 25.82, indicating a higher valuation compared to many of its peers. However, the P/E is below the industry average of 80.86, suggesting that while the stock is relatively expensive, it is not the highest within the sector.
The company’s P/B ratio of 5.37 is significantly above the industry median of 1.85, highlighting a potential overvaluation on a book value basis. The ROE of 8.31% is below the industry median of 10.59%, and the ROCE of 10.13% is also below the industry median of 12.98%. These figures suggest that Medico Remedies Ltd. is underperforming in terms of profitability compared to its industry peers.
The Healthcare sector, with 137 companies in the Pharmaceuticals & Drugs industry, shows a wide range of valuations and profitability metrics. Medico Remedies Ltd.’s market capitalisation of Rs 405.46 crore places it below the industry median of Rs 146.67 crore, indicating its position as a smaller player within the sector.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,945.17 | 30.21 | 0.44 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,835.92 | 0 | 2.35 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,652.68 | 39.86 | 8.11 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,608.51 | 63.2 | 10 | 18.65 | 22.17 |
| Panacea Biotec Ltd. | PANACEABIO | 2,589.99 | 0 | 3.07 | 0 | 5.36 |
Medico Remedies Ltd. (MEDICO) has a P/E ratio of 30.91x compared with the displayed peer median of 30.21x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.31% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Medico Remedies Ltd. (MEDICO) has a market capitalisation of Rs 405.46 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
When compared to its peers, Medico Remedies Ltd. shows mixed performance metrics. Dishman Carbogen Amcis Ltd. has a P/E of 30.21, slightly lower than Medico’s 30.91, while Kwality Pharmaceuticals Ltd. has a higher P/E of 39.86. Medico’s P/B ratio of 5.37 is higher than Dishman’s 0.44 and Kwality’s 8.11, indicating a higher valuation on a book value basis.
In terms of profitability, Medico’s ROE of 8.31% is higher than Dishman’s -2.89% but lower than Kwality’s 28.21%. The ROCE of 10.13% is also higher than Dishman’s -0.26% but lower than Kwality’s 26.35%. These comparisons highlight Medico Remedies Ltd.’s position relative to its peers, with a higher valuation and mixed profitability metrics.
Why Investors Are Watching Medico Remedies Ltd.
Investors are closely monitoring Medico Remedies Ltd. due to its recent price fall and its position within the Pharmaceuticals & Drugs industry. The company’s valuation and profitability metrics provide a mixed picture, attracting attention from market participants.
- Price Action: Significant 8.29% decline today.
- Technical Position: Elevated RSI indicating overbought conditions.
- Fundamental Context: High P/E and P/B ratios with below-average profitability.
- Sector Positioning: Smaller market cap within the Healthcare sector.
Investors should continue to monitor Medico Remedies Ltd.’s performance, particularly any changes in its valuation and profitability metrics, as well as broader market trends affecting the Pharmaceuticals & Drugs industry.
About Medico Remedies Ltd.
Medico Remedies Ltd. operates in the Pharmaceuticals & Drugs industry, focusing on the manufacturing and distribution of pharmaceutical products. The company is part of the Healthcare sector and has a market capitalisation of Rs 405.46 crore, positioning it as a smaller player within the industry.
Medico Remedies Ltd. offers a range of pharmaceutical products, catering to various therapeutic segments. The company’s operations are primarily based in India, and it competes with other pharmaceutical manufacturers in the region. Despite its smaller size, Medico Remedies Ltd. aims to maintain a competitive edge through its product offerings and market presence.
Track Medico Remedies Ltd. Share Price on Univest
Use Medico Remedies Ltd. (MEDICO) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.
Investors can track Medico Remedies Ltd. Share Price on Univest, where they can access live share price updates, technical indicators, fundamental ratios, shareholding patterns, and market insights. Univest provides comprehensive data and analysis to help investors make informed decisions about their investments in Medico Remedies Ltd. and other stocks.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What caused the decline in Medico Remedies Ltd. Share Price today?
Ans. Medico Remedies Ltd. Share Price fell 8.29% today, but the data does not specify a company-specific catalyst for this decline. It may be influenced by broader market trends. The stock moved -8.29% during the session.
How does Medico Remedies Ltd.'s P/E ratio compare to the industry?
Ans. Medico Remedies Ltd.'s P/E ratio of 30.91 is above the industry median of 25.82, indicating a relatively high valuation compared to many peers. The company trades at a P/E ratio of 30.91x.
What is Medico Remedies Ltd.'s market capitalisation?
Ans. Medico Remedies Ltd. has a market capitalisation of Rs 405.46 crore, placing it in the micro cap category within the Pharmaceuticals & Drugs industry. The company operates in the Healthcare sector.
How does Medico Remedies Ltd.'s ROE compare to the industry?
Ans. Medico Remedies Ltd.'s ROE of 8.31% is below the industry median of 10.59%, indicating lower profitability compared to many peers. ROE stands at 8.31%. ROCE stands at 10.13%. The relevant peer median ROE is 10.59%.
What is the significance of Medico Remedies Ltd.'s P/B ratio?
Ans. Medico Remedies Ltd.'s P/B ratio of 5.37 is significantly above the industry median of 1.85, suggesting a potential overvaluation on a book value basis. The company trades at a P/E ratio of 30.91x.
How does Medico Remedies Ltd.'s ROCE compare to the industry?
Ans. Medico Remedies Ltd.'s ROCE of 10.13% is below the industry median of 12.98%, indicating lower efficiency in capital utilization compared to peers. ROE stands at 8.31%. ROCE stands at 10.13%.
What industry does Medico Remedies Ltd. operate in?
Ans. Medico Remedies Ltd. operates in the Pharmaceuticals & Drugs industry, part of the broader Healthcare sector. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.
